2. As of noon trading, Novartis ( NVS) is down $0.37 (-0.6%) to $60.29 on light volume Thus far, 641,534 shares of Novartis exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $60.20-$60.45 after having opened the day at $60.43 as compared to the previous trading day's close of $60.66.

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Novartis has a market cap of $147.1 billion and is part of the health care sector. The company has a P/E ratio of 16.1, below the S&P 500 P/E ratio of 17.7. Shares are up 6.1% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Novartis a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Novartis as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Novartis Ratings Report now.

If you liked this article you might like

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

3 Biotech Stocks on Readers' Minds